Resources

Coulter Partners recently partnered with QBiotics Group Limited (QBiotics) and is pleased to announce the placement of Stephen Doyle as Chief Executive Officer, and of two Non-executive Directors to its Board, namely Mark Fladrich and David Phillips.

STEaPP’s PIU together with VaxHub Global and VaxHub Sustainable hosted the VaxHub Futures Forum on Pandemic Preparedness during UCL’s Festival of Engineering.

With a little over eight weeks to go to London Life Sciences Week (LLSW), we are launching a new website - lifesciencesweek.london - and lifting the lid on all that is happening to make the UK the place to be for life sciences this November. Continue reading for updates on NHS, £12 million Innovate UK funding, and more!

A new report from Manchester Metropolitan University, Force for Impact, shows that degree apprenticeships drive productivity and tackle key skills gaps.

Suil Vision has launched with £500k of seed funding from Cancer Research Horizons. The new company aims to create a market-ready biological data visualisation tool for researchers.

Arecor presents data from trial of ultra-concentrated, ultra-rapid acting insulin in overweight and obese people.

Steve Bates OBE, CEO of BIA, responds to BVCA’s recommendations on increasing pensions investment in fast-growing businesses.

Twenty-three companies will benefit from a share of £12 million from the Innovate UK Cancer Therapeutics programme. The Cancer Therapeutics programme focuses on developing life-changing cancer treatments, including immunotherapies and vaccines.

Innovate UK Phage Innovation Network has published a report entitled: Developing and delivering phage-based technologies in the UK.

PIR International is pleased to announce the appointment of Dieter Weinand as Non-Executive Chair at Anaveon.

This week I’ve been engaging with City and Government figures seeking to develop practical measures enabling UK life science to deliver our full growth potential. The key autumn dates remain the Government’s International Investment Summit on 14 October and the Budget on 30 October but the debate about what should be in this is already well underway.

With an initial investment of £28 million in resource and funding from LifeArc and Cancer Research UK, the consortium will bring together researchers, clinicians, scientists and industry to provide support, finance and expertise to progress innovations for children and young people’s cancers.

The BIA partnered with KQ Labs to host our Techbioboost event.

Newcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human outcomes, today announced the launch of its proprietary CiliaBeat software and application in a Lung Ciliary Beat Frequency Analysis assay.

Myricx Bio joins Kadans’ pioneering innovation centre in Canary Wharf, providing the facilities for its future expansion and pipeline progression.

Coulter Partners recently partnered with Compass Pathways (Nasdaq: CMPS) (“Compass”) and is pleased to announce the placement of Gino Santini as Chairman of its Board of Directors and Michael Gold, MD as Chief Research and Development Officer.